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Abstract 17 
The ‘gold standard’ method for detecting chlamydial infection in domestic and wild 18 
animals is PCR. However, this technique is not suited to testing animals ‘in the field’ when a 19 
rapid diagnosis is frequently required. The objective of this study was to compare the results 20 
of a commercially available enzyme immunoassay, the ‘Clearview’ (CLV) Chlamydia test, 21 
against a quantitative Chlamydia pecorum-specific PCR performed on swabs collected from 22 
the conjunctival sac, nasal cavity and urogenital sinuses of naturally infected koalas 23 
(Phascolarctos cinereus). The level of agreement for positive results between the two assays 24 
was low (43.2%). The CLV detection cut-off was determined as approximately 400 C. 25 
pecorum copies, indicating that this assay is sufficiently sensitive to be used for the rapid 26 
diagnosis of active chlamydial infections.     27 
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Members of the family Chlamydiaceae are obligate intracellular pathogens and 32 
important causes of disease in humans, domestic animals and wildlife (Longbottom and 33 
Coulter, 2003). Chlamydia infection is typically included as one of the differential diagnosis 34 
for a range of presenting clinical signs in animals such as ovine abortion and chronic kerato-35 
conjunctivitis and cystitis in koalas (Phascolarctos cinereus) (Sachse et al., 2009). However, 36 
subclinical infections can result in ‘healthy’ shedder animals within populations (Wan et al., 37 
2011), and infection with other pathogens may result in similar clinical signs. In 38 
consequence, veterinarians require additional diagnostic techniques to make a definitive 39 
diagnosis of chlamydial disease, particularly when disease is subclinical.  40 
 41 
The ‘Clearview’ (CLV) enzyme immunoassay (EIA) is a qualitative, solid-phase 42 
direct antigen detection method that employs an antibody directed against the 43 
Chlamydiaceae-family-specific lipopolysaccharide (cLPS). Compared to ‘gold standard’ tests 44 
such as cell culture and nucleic acid amplification (NAA) for detecting C. trachomatis genital 45 
tract infections, the CLV is less sensitive but is highly specific for members of the 46 
Chlamydiaceae in humans (Hislop et al., 2010). Similar, rapid point-of-care tests are rarely 47 
performed, however, due to this reduced sensitivity (van Dommelen et al., 2010). Published 48 
reports on the use of the CLV to detect chlamydial strains affecting mammals and birds are 49 
limited (Wood and Timms, 1992; Vanrompay et al., 1994), and when used in turkeys, 50 
significant numbers of false positives and negatives were found (Vanrompay et al., 1994). 51 
Despite these limitations, the CLV has significant potential in the diagnosis of chlamydial 52 
infection in animals, providing adequate sensitivity and specificity can be demonstrated. 53 
  54 
We commonly employ the CLV in field-testing for chlamydial infection in koalas 55 
(Wood and Timms, 1992). Of the two species that infect the koala, C. pecorum and C. 56 
 
 
pneumoniae, the former is both more pathogenic and prevalent than the latter (Jackson et al., 57 
1999; Devereaux et al., 2003; Marsh et al., 2011). To evaluate the sensitivity of the CLV in 58 
diagnosing C. pecorum infection in a ‘point-of-care’ setting, we collected swabs from the 59 
conjunctival sac, nasal cavity and urogenital tract of 36 koalas and compared the result of the 60 
CLV with the C. pecorum DNA copy number, as determined by quantitative PCR (Wan et 61 
al., 2011). The sampled koalas were presented to the Australia Zoo Wildlife Hospital, 62 
Beerwah, Australia, for veterinary treatment because of injury or illness. Duplicate cotton-63 
tipped swabs for qPCR and CLV were concurrently collected from the conjunctival sac, nasal 64 
cavity and urogenital sinus (females), or sequentially from the urethra (males). Duplicate 65 
urethral swabs from males were randomly assigned to the ‘CLV’ or ‘PCR’ test groups. All 66 
swabs were collected by the same clinician, and it was not possible to obtain samples from all 67 
sites in several animals.  68 
 69 
The CLV was performed within 20 min of sampling in accordance with the 70 
manufacturer’s instructions. ‘Result’ and ‘control’ windows were examined 15 min after 71 
applying the extract to the test strips, and were graded semiquantitatively as: 0, negative; 1, 72 
weakly positive (but could be clearly discerned); 2, strongly positive (but with less intense 73 
banding than the positive control); 3, band intensity ≥ positive control band (Fig. 1). The 74 
duplicate swab was stored at -80 °C prior to processing for qPCR as previously described 75 
(Wan et al., 2011). Samples with < 30 16S rDNA copies of C. pecorum DNA/µL were 76 
considered negative. 77 
 78 
The geometric mean C. pecorum DNA copy number at the sampled sites relative to 79 
the CLV result, and the specificity and sensitivity of CLV at each site are detailed in Table 1. 80 
As no CLV result was graded as ‘3’, this level of positivity was excluded from the analysis. 81 
 
 
Of 138 swabs, 81 (58.7%) were qPCR positive and 35 of these 81 were CLV positive, 82 
indicating 43.2% agreement. The approximate detection limit of the CLV was 384 C. 83 
pecorum cells/µL of swab material. Although this level of agreement level is lower than that 84 
found in a previous study in koalas where cell culture was used (Wood and Timms, 1992), 85 
the findings are consistent with NAA test/CLV comparisons (Hislop et al., 2010). This result 86 
is also not surprising considering that qPCR is considered more sensitive than an EIA in 87 
detecting chlamydial infection (Sachse et al., 2009). Sampling error, including the potential 88 
failure to collect equal numbers of chlamydial cells in both swabs may also have contributed 89 
to this finding.  90 
 91 
When sampling sites were compared (Table 1), the lowest agreement was observed 92 
from swabs collected from the nasal cavity (5 CLV positive vs. 17 qPCR positive; 29.4%), 93 
likely reflecting the lower load of C. pecorum in these swabs compared to other sites. The 94 
CLV was more reliable for swabs of the urogenital region (15 CLV positive vs. 25 qPCR 95 
positive; 60%), where the average qPCR copy number was approximately 10 times higher 96 
(Table 1). Four ‘false positive’ CLV results were detected in 57 C. pecorum DNA negative 97 
swabs, possibly because of the presence of other Chlamydiaceae, such as C. pneumoniae, 98 
which are known to infect wild koalas at a much lower prevalence (Jackson et al., 1999). 99 
There is also evidence that other, Chlamydia-like organisms infect koalas (Devereaux et al., 100 
2003), although there is no data currently available on the potential for CLV to cross-react 101 
with these organisms.  102 
 103 
Interestingly, CLV signal semiquantitative grading correlated strongly with the C. 104 
pecorum infectious load (P < 0.05; one-way ANOVA), suggesting that when sufficient C. 105 
pecorum organisms are present (i.e. approximately 400 C. pecorum copies /µL), subjective 106 
 
 
reading of the CLV signal at the recommended time could be used to semi-quantify 107 
chlamydial infection loads. Based on our recent study examining the relationship between C. 108 
pecorum infectious load in koalas, and disease severity, this finding suggests the CLV is 109 
potentially suitable for confirming chlamydiosis in animals with active disease affecting the 110 
eye or urogenital regions, as the infectious load in these animals is within this detection range 111 
(Wan et al., 2011). However, the test may not be reliable in: detecting subclinically infected 112 
animals with infectious loads < 400 copies/µL; confirming C. pecorum infection in animals 113 
with chronic, inactive disease, as such animals often shed levels of organisms below the 114 
detection threshold of this assay (Wan et al., 2011). 115 
  116 
          In conclusion, when the portability, turn-around time and ease of use of the CLV are 117 
considered, this assay is a useful adjunct clinical test in the diagnosis of chlamydial infection 118 
in animals, as demonstrated in our study in the koala. Further work will be required to 119 
validate its diagnostic value in other species. 120 
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Table 1.  182 
 183 
Details of the sensitivity and specificity of the ‘Clearview’ (CLV) enzyme immunoassay 184 
antigen detection test compared with a Chlamydia pecorum species-specific qPCR assay 185 
carried out on swabs taken from the conjunctival sac (conjun), nasal cavity, and urogenital 186 
tract (UGT) of naturally infected koalas.   187 
 188 
CLV 
band 
intensity  
‘score’ 
No.  
of 
swabs 
qPCR 
16S 
copies a 
No. of PCR positives (n 
= 81) diagnosed as: 
No. of PCR negatives (n 
= 57) diagnosed as: Sensitivity b Specificity c CLV 
positive 
CLV 
negative 
CLV 
positive 
CLV 
negative 
Negative 99 1 - 46 - 53 - - 
+ 20 384 18 - 2 - - - 
++ 19 1385 17 - 2 - - - 
Total 
(all) 138 - 35 46 4 53 43.2 92.9 
Conjun 
swabs 69 67 15 25 2 27 37.5 93.1 
Nasal 
swabs 35 36 5 12 1 17 29.4 94.4 
UGT 
swabs 34 291 15 10 1 8 60.0 88.9 
a Geometric mean copies of 16S rDNA PCR product/µL of DNA/swab. 189 
b Sensitivity, % number of positives detected against number PCR positive. 190 
c Specificity, % number of negatives detected against number PCR negative. 191 
192 
 
 
Figure legend 193 
 194 
Fig. 1.  195 
The ‘Clearview’ (CLV) enzyme immunoassay is a qualitative, solid-phase direct antigen 196 
detection method that employs an antibody directed against the Chlamydiaceae-family-197 
specific lipopolysaccharide. The semiquantitative grading system used in this study is 198 
illustrated. ‘Control’ and ‘result’ windows were examined 15 min after applying the extract to 199 
the test strips, and were graded as: 0, negative; 1, weakly positive (but could be clearly 200 
discerned); 2, strongly positive (but with less intense banding than the positive control); 3, 201 
band intensity ≥ positive control band.  202 
 203 
